The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of actionable mutations in surgically resected tumor specimens from Japanese patients with non-small cell lung cancer by ultra-deep targeted sequencing.
Yasuhiro Koh
No relevant relationships to disclose
Hirotsugu Kenmotsu
No relevant relationships to disclose
Masakuni Serizawa
No relevant relationships to disclose
Mitsuhiro Isaka
No relevant relationships to disclose
Keita Mori
No relevant relationships to disclose
Hisao Imai
No relevant relationships to disclose
Hiroaki Akamatsu
No relevant relationships to disclose
Akira Ono
No relevant relationships to disclose
Tateaki Naito
No relevant relationships to disclose
Tetsuhiko Taira
No relevant relationships to disclose
Haruyasu Murakami
No relevant relationships to disclose
Toshiaki Takahashi
No relevant relationships to disclose
Masahiro Endo
No relevant relationships to disclose
Takashi Nakajima
No relevant relationships to disclose
Yasuhisa Ohde
No relevant relationships to disclose
Nobuyuki Yamamoto
No relevant relationships to disclose